Evidence map›Paper›PMID 23321216›Full record

Trial reportDiabetes care2013

Evaluation of a self-administered oral glucose tolerance test.

M Angelyn Bethel, Hermione C Price, Harald Sourij, Sarah White, Ruth L Coleman, Arne Ring, Irene E C Kennedy, Lynne Tucker, Rury R Holman

2 registry-linked trialsOpen access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in Diabetes care, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02703155 naunknown statusnot on this mapstarted 2015, after this paper: background citation

The Use of Self-Administered Electronic Oral Glucose Tolerance Test Kit in Screening Cystic Fibrosis Related Diabetes in Children With Cystic Fibrosis

TypeinterventionalSponsorGreat Ormond Street Hospital for Children NHS Foundation TrustRan2015 to 2016Enrolled30ConditionsCystic Fibrosis Related Diabetes, Cystic FibrosisArmsHome Oral Glucose Tolerance Test kit
NCT06815081 recruitingnot on this mapstarted 2024, after this paper: background citation

A Study to Determine a Capillary Alternative to the Gold Standard Oral Glucose Tolerance Test

TypeobservationalSponsorUniversity of OxfordRan2024 to 2027Enrolled135ConditionsType 1 Diabetes (T1D), Type 2 Diabetes
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Review
  3. Pregnancy as an opportunity to prevent type 2 diabetes mellitus: FIGO Best Practice Advice.International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics · 2023
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

M Angelyn BethelDiabetes Trials Unit Translational Research Group, Oxford Centre for Diabetes, Endocrinology, and Metabolism, University of Oxford, Oxford, United Kingdom. angelyn.bethel@dtu.ox.ac.uk
Hermione C Price
Harald Sourij
Sarah White
Ruth L Coleman
Arne Ring
Irene E C Kennedy
Lynne Tucker
Rury R Holman
Oxford BioMedica (United Kingdom) · GBOxford Centre for Diabetes, Endocrinology and Metabolism · GBUniversity of Oxford · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo assess the feasibility of using a disposable, self-administered, capillary blood sampling oral glucose tolerance test (OGTT) device in a community setting. RESEARCH DESIGN AND

methodsEighteen healthy and 12 type 2 diabetic volunteers underwent six 75-g OGTTs using a prototype device in the following three settings: unaided at home (twice); unaided but observed in clinic (twice); and performed by a nurse with simultaneous laboratory glucose assays of 0- and 120-min venous plasma samples (twice). The device displayed no results. A detachable data recorder returned to the clinic provided plasma-equivalent 0- and 120-min glucose values and key parameters, including test date, start and end times, and time taken to consume the glucose drink.

resultsThe device was universally popular with participants and was perceived as easy to use, and the ability to test at home was well liked. Device failures meant that 0- and 120-min glucose values were obtained for only 141 (78%) of the 180 OGTTs performed, independent of setting. Device glucose measurements showed a mean bias compared with laboratory-measured values of +0.9 at 5.0 mmol/L increasing to +4.4 at 15.0 mmol/L. Paired device glucose values were equally reproducible across settings, with repeat testing showing no training effect regardless of setting order.

conclusionsSelf-administered OGTTs can be performed successfully by untrained individuals in a community setting. With improved device reliability and appropriate calibration, this novel technology could be used in routine practice to screen people who might need a formal OGTT to confirm the presence of impaired glucose tolerance or diabetes.

Indexed as

Glucose Tolerance TestAgedFemaleHumansMaleMiddle AgedSelf Administration

Identifiers

PMID23321216
PMCPMC3661807
OpenAlexW2140541557

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.